SCNXHIGH SIGNALRISK10-K

SCNX shows severe financial deterioration with a massive swing from $9.1M profit to -$41.5M loss while outstanding shares increased 225% indicating significant dilution.

The dramatic increase in shares outstanding from 12.5M to 40.6M represents massive dilution to existing shareholders, while the company swung from profitability to deep losses despite revenue growth. The language changes emphasize going concern risks and capital raising challenges, suggesting the company is in financial distress despite improved cash position.

Comparing 2026-03-30 vs 2025-03-26View on EDGAR →
FINANCIAL ANALYSIS

Despite strong operational improvements with gross profit surging from $6K to $331K and cash increasing dramatically to $6.7M, the overall financial picture is deeply concerning due to the $50M negative swing in net income and 225% increase in shares outstanding. Operating losses nearly tripled to -$42.6M while interest expense surged 256%, and dividends paid increased nearly 6x to $14.9M, suggesting unsustainable cash outflows. The combination of massive dilution, deteriorating profitability, and substantial debt increase of over 1,100% signals a company in severe financial distress despite some operational progress.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
+21946.3%
968$213K

Inventory surged 21946.3% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Accounts Receivable
Balance Sheet
+6485%
$11K$731K

Receivables surged 6485% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Gross Profit
P&L
+5420.1%
$6K$331K

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Cash & Equivalents
Balance Sheet
+4285.6%
$152K$6.7M

Cash position surged 4285.6% — strong cash generation or capital raise providing significant financial cushion.

Total Debt
Balance Sheet
+1187.9%
$225K$2.9M

Debt increased 1187.9% — substantial leverage increase; assess whether deployed for growth or covering losses.

Dividends Paid
Cash Flow
+579.2%
$2.2M$14.9M

Dividend payments increased 579.2% — management confidence in sustained cash generation.

Net Income
P&L
-557.9%
$9.1M-$41.5M

Net income declined 557.9% — review whether driven by operations, interest costs, or non-recurring items.

Interest Expense
P&L
+256.4%
$336K$1.2M

Interest expense surged 256.4% — significant debt increase or rising rates materially impacting earnings.

Operating Income
P&L
-189.7%
-$14.7M-$42.6M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Current Liabilities
Balance Sheet
-65.4%
$7.9M$2.7M

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-03-26
ADDED
There were 40,630,815 shares of the registrant s common stock outstanding on March 27, 2026.
Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Annual Report relates.
Some of the statements in this Annual Report constitute forward-looking statements because they relate to future events or our future performance or future financial condition.
These risks include, among others, the following: We operate a clinical-stage biopharmaceutical company with a limited operating history, which may make it difficult to evaluate its current business and predict its future success and viability.
We need additional capital which may not be available when needed or on commercially acceptable terms, thereby casting substantial doubt on our ability to continue as a going concern.
+7 more — sign up free →
REMOVED
Employer Identification No.) 6308 Benjamin Rd , Suite 708 Tampa , Florida 33634 (Address of principal executive offices) (Zip code) (800) 261-0281 (Registrant s telephone number, including area code) TRxADE HEALTH, INC.
There were 12,515,019 shares of the registrant s common stock outstanding on March 26, 2025.
Securities and Exchange Commission (the SEC ) on January 27, 2025, and the related additional soliciting materials filed with the SEC on February 18, 2025 within 120 days after the end of the fiscal year to which this Annual Report relates.
Some of the statements in this Registration Statement constitute forward-looking statements because they relate to future events or our future performance or future financial condition.
We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
+7 more — sign up free →
MORE RISK SIGNALS
CAPSHIGHCAPS underwent a major business expansion through acquisitions while experiencin...
2026-04-16
KALAHIGHKALA has undergone a dramatic business transformation with massive share dilutio...
2026-04-15
RAINHIGHRain Enhancement Technologies underwent a financial restatement revealing signif...
2026-04-15
POLAHIGHPOLA experienced severe financial deterioration with gross profit turning negati...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →